Ceftolozane/Tazobactam Dose Selection for Pediatric Patients (birth to < 18 years)

被引：0
|
作者：
Larson, Kajal B. [1 ]
Patel, Yogesh T. [2 ]
Willavize, Susan [2 ]
Rizk, Matthew L. [1 ]
Yu, Brian [1 ]
Johnson, Matthew G. [1 ]
Rhee, Elizabeth G. [1 ]
Caro, Luzelena [1 ]
机构：
[1] Merck & Co Inc, Kenilworth, NJ USA
[2] Cognigen Corp, Buffalo, NY USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
T-078
引用
收藏
页码：S87 / S87
页数：1
相关论文
共 50 条
  • [1] CEFTOLOZANE-TAZOBACTAM DOSE SELECTION FOR CLINICAL EVALUATION IN PEDIATRIC PATIENTS WITH NOSOCOMIAL PNEUMONIA USING A BAYESIAN APPROACH.
    Zhang, Z.
    Patel, Y.
    Fiedler-Kelly, J.
    Feng, H.
    Johnson, M.
    Rhee, E.
    Huntington, J.
    Rizk, M.
    Gao, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S30 - S30
  • [2] CEFTOLOZANE-TAZOBACTAM DOSE SELECTION FOR CLINICAL EVALUATION IN PEDIATRIC PATIENTS WITH NOSOCOMIAL PNEUMONIA USING A BAYESIAN APPROACH.
    Zhang, Z.
    Patel, Y.
    Fiedler-Kelly, J.
    Feng, H.
    Johnson, M.
    Rhee, E.
    Huntington, J.
    Rizk, M.
    Gao, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S9 - S9
  • [3] Plasma pharmacokinetics of ceftolozane/tazobactam in pediatric patients with cystic fibrosis
    Arrieta, Antonio C.
    Ang, Jocelyn Y.
    Zhang, Zufei
    Larson, Kajal B.
    Yu, Brian
    Johnson, Matthew G.
    Rhee, Elizabeth G.
    Feng, Ed H.
    Rizk, Matthew L.
    PEDIATRIC PULMONOLOGY, 2020, 55 (08) : 2025 - 2032
  • [4] Prescribing Ceftolozane/Tazobactam for Pediatric Patients: Current Status and Future Implications
    Tamma, Seetha M.
    Hsu, Alice J.
    Tamma, Pranita D.
    PEDIATRIC DRUGS, 2016, 18 (01) : 1 - 11
  • [5] Prescribing Ceftolozane/Tazobactam for Pediatric Patients: Current Status and Future Implications
    Seetha M. Tamma
    Alice J. Hsu
    Pranita D. Tamma
    Pediatric Drugs, 2016, 18 : 1 - 11
  • [6] Ceftolozane-Tazobactam Population Pharmacokinetics and Dose Selection for Further Clinical Evaluation in Pediatric Patients with Complicated Urinary Tract or Complicated lntra-abdominal Infections
    Larson, Kajal B.
    Patel, Yogesh T.
    Willavize, Susan
    Bradley, John S.
    Rhee, Elizabeth G.
    Caro, Luzelena
    Rizk, Matthew L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (06)
  • [7] Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia
    Xiao, Alan J.
    Miller, Benjamin W.
    Huntington, Jennifer A.
    Nicolau, David P.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (01): : 56 - 66
  • [8] Birth mode in 381 women < 18 years:: a case control study
    Schmid, M.
    Bentz, E. K.
    Huber, J.
    Keck, C.
    Hefler, L.
    Tempfer, C.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (05) : 545 - 545
  • [9] Population Pharmacokinetics of Tapentadol in Children from Birth to <18 Years Old
    Khalil, Feras
    Choi, Siak Leng
    Watson, Estelle
    Tzschentke, Thomas M.
    Lefeber, Claudia
    Eerdekens, Marielle
    Freijer, Jan
    JOURNAL OF PAIN RESEARCH, 2020, 13 : 3107 - 3123
  • [10] Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged < 18 years
    Handley, S.
    Couchman, L.
    Bowskill, S.
    Patel, M.
    Flanagan, R.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 527 - 527
12345